Minimal Residual Disease or Cure in MPNs? Rationales and perspectives on Combo Therapy with Interferon-alpha2 and RuxolitinibJune 29, 2017
ASH 2017 Nutlin Antagonist Shows Activity in Polycythemia VeraDecember 27, 2017
A Few Simple Criteria
If your doc has never been to the ASH (American Society of Hematology) conference, the largest hematology convention in the world and never published a peer reviewed research paper, he/she ain’t likely to be an MPN specialist. Also, if their bio lists 12+ clinical interests, their focus is NOT likely on MPN’s. 4 to 6 clinical interests would be a reasonable amount to maintain a research study focus on Myeloproliferative Neoplasms.
- Past or present participation in a clinical trial is also a good indicator.
- They should stay abreast of the latest MPN research (that’s crucial).
- Your doctor should see 50 (at least) to 500+ patients a year. If you ask your doc “how many PV, ET or MF patients do you treat?” and they say “3 or 4” you are not seeing an MPN specialist.
- It took me 6 prior doctors to find a specialist I can trust with my life, so I know the red flags to look for.
Are you Looking for an MPN Specialist?
Click here for a “Doctor Reviewed” list of MPN Specialist in the U.S.